Skip to content

A pilot study: 4 MHz monopolar radio frequency application in facial rejuvenation

A pilot study: 4 MHz monopolar radio frequency application in facial rejuvenation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110306
Enrollment
Unknown
Registered
2025-10-11
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin aging

Interventions

Experimental group:4 MHz unipolar radio frequency device (TempSure) treatment

Sponsors

Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 35–50 years (including 35 and 50 years), regardless of gender; 2. Bilateral facial symmetry is basically maintained; 3. Patients with mild to moderate facial skin aging with an FWS score >=1; 4. No contraindications to RF and electrical stimulation treatments; 5. Not engaged in outdoor occupations; 6. Patients with good compliance, able to cooperate with follow-ups; 7. Voluntarily participate in this study and sign the informed consent form willingly.

Exclusion criteria

Exclusion criteria: 1. Metal implants in the body (such as dentures, pacemakers, artificial joints, etc.); 2. Pregnant women, lactating women, or women who have plans to conceive within half a year after the end of the study; 3. The treatment area is combined with other skin diseases (such as eczema, allergic dermatitis, severe melasma, psoriasis, rosacea, etc.) that may interfere with the treatment or evaluation of facial rejuvenation, or scars and excessive hair that significantly affect the observation of the effect; 4. Participate in other clinical studies of eye rejuvenation during the study period; 5. Those who are unwilling to stop using other non-medical energy equipment stimulation during the study period and take good sun protection; 6. Those who have received any facial rejuvenation treatment (such as drugs, lasers, intense pulsed light, radiofrequency, ultrasound, photodynamic therapy, etc.) in the past 4 weeks before enrollment; 7. Combined systemic diseases: including but not limited to tumors, history of cardiovascular disease, endocrine diseases (such as diabetes, dyslipidemia, abnormal thyroid function, etc.), hematological diseases (such as anemia, abnormal coagulation mechanism, etc.) or infectious diseases (such as herpes, etc.).

Design outcomes

Primary

MeasureTime frame
Fitzpatrick Skin Wrinkle and Elasticity Scale score;Pain Visual Analog Scale;

Secondary

MeasureTime frame
Elasticity of the skin around the eyes;GAIS score around the eyes;

Countries

China

Contacts

Public ContactMin Yao

Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine

my058@vip.sina.com+86 189 1779 7606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026